The amount of liabilities representing income that has been received (or the amount is due) but is not yet earned, including contract liabilities. [Refer: Contract liabilities]

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Note Expiry date 2027-01-01
-Name IAS
-Number 1
-IssueDate 2025-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Note Expiry date 2027-01-01
-Name IAS
-Number 1
-IssueDate 2025-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_DeferredIncomeIncludingContractLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash inflow from issuing shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2025-01-01
-Paragraph 17
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_ProceedsFromIssuingShares
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash inflow from sales of goods and rendering of services.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2025-01-01
-Paragraph 14
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14_a&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_ReceiptsFromSalesOfGoodsAndRenderingOfServices
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Additional consideration to be received if counterparty exercises option to expand partnership

+ References

No definition available.

+ Details

Name:	prqr_AdditionalConsiderationToBeReceivedIfCounterpartyExercisesOptionToExpandPartnership
Namespace Prefix:	prqr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of discount on issue of shares.

+ References

No definition available.

+ Details

Name:	prqr_DiscountOnIssueOfShares
Namespace Prefix:	prqr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of new stock shares issued during the period.

+ References

No definition available.

+ Details

Name:	prqr_IfrsStockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	prqr_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of performance obligations in collaboration agreement

+ References

No definition available.

+ Details

Name:	prqr_NumberOfPerformanceObligationsInCollaborationAgreement
Namespace Prefix:	prqr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Value of milestones reached during the period.

+ References

No definition available.

+ Details

Name:	prqr_ValueOfMilestonesReachedDuringPeriod
Namespace Prefix:	prqr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	ifrs-full_CounterpartiesAxis=prqr_EliLillyAndCompanyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_ProductsAndServicesAxis=prqr_MilestonePaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Revenue (Details)	1 Months Ended								6 Months Ended
Revenue (Details)	Feb. 28, 2023 EUR (€)	Feb. 28, 2023 USD ($)	Dec. 31, 2022 EUR (€) shares	Dec. 31, 2022 USD ($) shares	Oct. 31, 2021 EUR (€)	Oct. 31, 2021 USD ($)	Sep. 30, 2021 EUR (€) shares	Sep. 30, 2021 USD ($) shares	Jun. 30, 2026 USD ($)	Jun. 30, 2026 EUR (€)	Jun. 30, 2026 USD ($)	Dec. 31, 2025 EUR (€)	Sep. 30, 2021 USD ($)
Disclosure of disaggregation of revenue from contracts with customers [line items]
Deferred income \| €										€ 28,154,000		€ 38,946,000
Eli Lilly and Company
Disclosure of disaggregation of revenue from contracts with customers [line items]
Deferred income							€ 2,047,000			€ 28,154,000		€ 38,946,000	$ 2,429,000
Issue of ordinary shares (in shares) \| shares			9,381,586	9,381,586			3,989,976	3,989,976
Proceeds from issuing shares			€ 14,122,000	$ 15,000,000			€ 25,270,000	$ 30,000,000
Discount on shares issued			€ 451,000	$ 480,000
Additional consideration to be received if counterparty exercises option to expand partnership											$ 50,000,000
Number of performance obligations in collaboration agreement										1	1
Milestone payments received					€ 16,849,000	$ 20,000,000
Value of milestones reached during the period									$ 0
Eli Lilly and Company \| Milestone payments
Disclosure of disaggregation of revenue from contracts with customers [line items]
Milestone payments received	€ 56,412,000	$ 60,000,000